🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

1,428 notícias encontradas para "target"
Intravesical CAR T therapy opens door to bladder-sparing cancer treatment
Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The study, published in the Journal of Experimental Medicine (
New research may lead to a vaccine against severe diarrhea
New research may lead to a vaccine against severe diarrhea
Research led by the University of Bergen (UiB) and NORCE may help pave the way for a new vaccine targeting one of the world's leading causes of severe diarrheal disease. The technology has now been licensed to the international vaccine company Valneva, which will take the work fo
Researchers discover new driver of asthma-related inflammation
Researchers discover new driver of asthma-related inflammation
Researchers at National Jewish Health have uncovered a previously unknown mechanism that helps drive inflammation in allergic asthma, offering new insight into how the disease develops and potentially revealing new targets for future therapies.
VR combined with nerve stimulation improves arm and hand function following a stroke
Researchers at the Medical University of Vienna and ETH Zurich have developed a rehabilitation platform for people suffering from the long-term effects of a stroke that combines virtual reality with targeted sensory nerve stimulation. In a randomized feasibility clinical study wi
Foto: Tara Winstead / Pexels
Emerging mRNA vaccine strategies target cancer and pathogenic viruses in potent new ways
The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research reveals that a crucial T-cell population can be reprogrammed in animal models by reimagining the science that was introduced to the public at the height of the p
Foto: Anna Tarazevich / Pexels
New therapeutic target for cancer identified by revealing how cancer 'hijacks' blueprint f
Anti-angiogenic therapies targeting VEGF have been widely used in cancer treatment, yet their long-term efficacy remains limited. Tumor vascular endothelial cells (TECs) exhibit high adaptive plasticity, enabling them to resist treatment and sustain tumor growth, but the molecula
Foto: Maksim Goncharenok / Pexels
Same day administration of COVID-19 and influenza vaccines not associated with increase in
A target trial emulation found that same-day coadministration of the COVID-19 and influenza vaccines was not associated with a higher risk of serious or clinically meaningful adverse events compared with receiving only an influenza vaccine. Across multiple updated COVID-19 vaccin
Cancer cell 'degraders' target two proteins at once to defeat treatment resistance
Cancer cell 'degraders' target two proteins at once to defeat treatment resistance
Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.
CAR T cell therapy targets key mutation driving rare blood cancers
CAR T cell therapy targets key mutation driving rare blood cancers
A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to new research led by UCL and Univers
Foto: roberto carrafa / Pexels
Investigators report promising results from Phase II trial of targeted therapy for rare bi
Results of the ongoing eNRGy trial, a single-arm, multicenter, global Phase II clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically meaningful efficacy—including a near doubling of p
Study identifies new brain targets for individualized epilepsy treatment
Study identifies new brain targets for individualized epilepsy treatment
Mayo Clinic researchers have created a detailed map of the pulvinar, a deep brain region that could help doctors more precisely target brain stimulation therapies for people with drug-resistant epilepsy.
Anion gap remains pragmatic target during diabetic ketoacidosis treatment and resolution
Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring as they receive insulin infusions and other medical interventions to bring their blood glucose and ketone levels back into balance.